Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis

Oncogene

Volumn 35, Issue 18, 2016, Pages 2370-2378

  Meng, X ^a   Vander Ark, A ^a   Lee, P ^a   Hostetter, G ^a   Bhowmick, N A ^b   Matrisian, L M ^c   Williams, B O ^a   Miranti, C K ^a   Li, X ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Pancreatic Cancer Action Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; CANCER ANTIBODY; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MARROW CELL; BONE METASTASIS; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; MOLECULAR PATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; BONE TUMOR; BREAST TUMOR; CELL LINEAGE; CELL PROLIFERATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; PATHOLOGY; SECONDARY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTIBODIES, NEOPLASM; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; MICE; MYELOID CELLS; OSTEOCLASTS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84939445272     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.297     Document Type: Article

References (24)

1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12: 6243s-6249s.
2. Reddi AH, Roodman D, Freeman C, Mohla S. Mechanisms of tumor metastasis to the bone: challenges and opportunities. J Bone Miner Res 2003; 18: 190-194.
3. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 2010; 10: 415-424.
4. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-851.
5. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks. Oncogene 2005; 24: 5053-5068.
6. Cheng N, Chytil A, Shyr Y, Joly A, Moses HL. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis. Cancer Res 2007; 67: 4869-4877.
7. Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T et al. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 2008; 27: 7118-7130.
8. Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW et al. Loss of TGF-beta responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res 2012; 10: 494-503.
9. KimBG, Li C, QiaoW, Mamura M, Kasprzak B, AnverMet al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006; 441: 1015-1019.
10. Novitskiy SV, Pickup MW, Chytil A, Polosukhina D, Owens P, Moses HL. Deletion of TGF-beta signaling in myeloid cells enhances their anti-tumorigenic properties. J Leukoc Biol 2012; 92: 641-651.
11. Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP et al. TGF-beta signaling in myeloid cells is required for tumor metastasis. Cancer Discov 2013; 3: 936-951.
12. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116-129.
13. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 165-197.
14. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993; 81: 631-638.
15. Busch S, Acar A, Magnusson Y, Gregersson P, Ryden L, Landberg G. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer. Oncogene 2015; 34: 27-38.
16. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153-158.
17. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116-129.
18. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 1997; 57: 4360-4367.
19. Wan X, Corn PG, Yang J, Palanisamy N, Starbuck MW, Efstathiou E et al. Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Sci Transl Med 2014; 6: 252-122.
20. Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K et al. Tumorinduced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 2013; 24: 542-556.
21. Johnson RW, Merkel AR, Page JM, Ruppender NS, Guelcher SA, Sterling JA. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis 2014; 31: 945-959.
22. Chytil A, Magnuson MA, Wright CV, Moses HL. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 2002; 32: 73-75.
23. Zhong Z, Zylstra-Diegel CR, Schumacher CA, Baker JJ, Carpenter AC, Rao S et al. Wntless functions in mature osteoblasts to regulate bone mass. Proc Natl Acad Sci USA 2012; 109: E2197-E2204.
24. Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 2011; 19: 192-205.